Funded Startups in Ecublens
Across these 13 most recent Ecublens rounds, the largest disclosed financing is Lymphatica Medtech’s $20M (2024-10-08), which stands well above the rest of…
Across these 13 most recent Ecublens rounds, the largest disclosed financing is Lymphatica Medtech’s $20M (2024-10-08), which stands well above the rest of the disclosed amounts in this slice (the next-largest disclosed amounts are $35M for Anokion on 2022-10-18 and $9M for CREAL on 2025-07-10; several rounds cluster far lower). The dataset also shows a clear timing cluster: 2024 is the densest year in view, with four entries in 2024 (Picterra 2024-10-07, Lymphatica Medtech 2024-10-08, Enerdrape 2024-01-11, and one undisclosed-value entry), concentrated around October 2024 for the two AI/biotech entries.
Sector and classification skew: Biotechnology appears 4 times (bNovate Technologies 2025-02-21; Lymphatica Medtech 2024-10-08; Anokion 2022-10-18; Nanolive 2022-09-20). Stage labels are often not provided: 5 of 13 rows are “Series Unknown”/“Venture - Series Unknown” (CREAL 2025-07-10; bNovate Technologies 2025-02-21; Picterra 2024-10-07; Composite Recycling 2023-05-02; Anokion 2022-10-18), and 2 of 13 are explicitly “undisclosed” in amount (Picterra 2024-10-07 and AMF Medical SA 2021-11-01). Chronologically, the visible window runs from 2021-10-04 (Alpine Intuition) to 2025-07-10 (CREAL).
Most recent rounds
13 shownRelated listings
Frequently asked
Which disclosed round is the outlier, and how does it compare to the rest of the Ecublens list?
Anokion’s $35M (2022-10-18) is the standout disclosed amount in this 13-row slice; Lymphatica Medtech’s $20M (2024-10-08) is the next-largest disclosed figure, while several other rounds sit in the $2M–$9M range (e.g., Enerdrape $2M on 2024-01-11; Zaphiro Technologies $7M on 2022-12-19).
Do multiple rounds cluster in a narrow time window?
Yes. October 2024 accounts for back-to-back entries in this view: Picterra (AI) closed on 2024-10-07 and Lymphatica Medtech (Biotechnology) on 2024-10-08, with the two surrounding dates tightly packed compared with the broader 2021–2025 spread.
Is any sector over-represented among these Ecublens rounds?
Biotechnology is the most frequent sector in the 13 rows, appearing 4 times: bNovate Technologies ($4M, 2025-02-21), Lymphatica Medtech ($20M, 2024-10-08), Anokion ($35M, 2022-10-18), and Nanolive ($2M, 2022-09-20).
How much does the data rely on missing or non-standard stage/amount disclosures?
Stage categorization is incomplete for 5 of 13 rows via “Series Unknown” or “Venture - Series Unknown” (CREAL 2025-07-10; bNovate Technologies 2025-02-21; Picterra 2024-10-07; Composite Recycling 2023-05-02; Anokion 2022-10-18). Amount disclosure is also incomplete on 2 of 13 rows, both marked “undisclosed” (Picterra on 2024-10-07 and AMF Medical SA on 2021-11-01).
What stage mix dominates the list, based on the rounds with explicit stage labels?
Among rows with explicit stage labels, Seed and Series A show up repeatedly alongside later-stage rounds: Seeds include Enerdrape ($2M, 2024-01-11) and SoHHytec ($2M, 2022-01-20), while Series A includes Zaphiro Technologies ($7M, 2022-12-19) and Embion Technologies ($5M, 2021-12-08). Later-stage is represented by Series C Nanolive ($2M, 2022-09-20) and Series B Lymphatica Medtech ($20M, 2024-10-08).
Which entry is the smallest disclosed round in this slice, and what does it imply about dispersion?
Composite Recycling’s $30K (2023-05-02) is the smallest disclosed amount shown, far below other disclosed entries such as Alpine Intuition’s $100K (2021-10-04) and the $2M–$9M cluster (e.g., Enerdrape $2M on 2024-01-11; Nanolive $2M on 2022-09-20).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.